Figure’s 2025 plans for the home aren’t entirely clear, but “alpha” certainly implies that home testing will remain in the very early stages for the remainder of the year. Techcrunch event ...

Helix BioPharma Corp. Receives Regulatory Approval to Conduct a European Phase III Clinical Trial of Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions ...

Helix's product development initiatives include its Topical Interferon Alpha- 2b and its novel L-DOS47 new drug candidate. Helix is listed on the TSX under the symbol "HBP". For more information ...

Helix's product development initiatives include its novel L-DOS47 new drug candidate and its Topical Interferon Alpha-2b. Helix is currently listed on the TSX and FSE under the symbol "HBP." ...

"This is a significant step for Helix. We are seeking approval to conduct what we intend to be a second, confirmatory efficacy trial of Topical Interferon Alpha-2b in patients with low-grade cervical ...